BRIEF-Endo to continue collecting, analyzing data relating to OPANA ER

Fri Aug 12, 2016 7:26am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 12 (Reuters) - Endo International Plc :

* Endo announces OPANA ER regulatory update

* Plans to continue collecting and analyzing epidemiological data relating to OPANA ER

* Financial projections for 2016 did not assume approval of SNDA

* Endo announces OPANA ER regulatory update

* Says has decided to withdraw its supplemental new drug application (SNDA) relating to specific abuse deterrent labeling for OPANA ER Source text for Eikon: Further company coverage: